MEAD Trademark

Trademark Overview

On Friday, November 9, 2018, a trademark application was filed for MEAD with the United States Patent and Trademark Office. The USPTO has given the MEAD trademark a serial number of 88188384. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, September 12, 2019. This trademark is owned by Filtricine, Inc.. The MEAD trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Dietary and nutritional supplements; dietary and nutritional supplements used for dialysis; dietary and nutritional supplements for treating cancer; dietary and nutritional supplements for use in connection with a variety of therapeutic areas; dietary and nutritional supplements designed to remediate nutrient deprivation; dietary and nutritional supplements designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases; dietary and nutritional supplements for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics

Dietary and nutritional supplement research services; dietary and nutritional supplement research and development; research and development in dietary and nutritional supplements for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; dietary and nutritional supplement research in the field of dialysis; dietary and nutritional supplement research in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutrit...
mead

General Information

Serial Number88188384
Word MarkMEAD
Filing DateFriday, November 9, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, September 12, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDietary and nutritional supplements; dietary and nutritional supplements used for dialysis; dietary and nutritional supplements for treating cancer; dietary and nutritional supplements for use in connection with a variety of therapeutic areas; dietary and nutritional supplements designed to remediate nutrient deprivation; dietary and nutritional supplements designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases; dietary and nutritional supplements for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
Goods and ServicesDietary and nutritional supplement research services; dietary and nutritional supplement research and development; research and development in dietary and nutritional supplements for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; dietary and nutritional supplement research in the field of dialysis; dietary and nutritional supplement research in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutritional supplement research, namely, research relating to remediating nutrient deprivation for use in connection with a wide variety of therapeutic areas

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 27, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFiltricine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMountain View, CA 94043

Trademark Events

Event DateEvent Description
Thursday, September 12, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, September 12, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 14, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 14, 2019NON-FINAL ACTION E-MAILED
Thursday, February 14, 2019NON-FINAL ACTION WRITTEN
Thursday, February 14, 2019ASSIGNED TO EXAMINER
Tuesday, November 27, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 13, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

mead dietary nutritional supplements research including oncology supplement field medical cancer